The letter, published in 2001, argues that local anesthesia is a “safe, reliable, inexpensive, and practical alternative to the use of epidural, spinal, or general anesthesia” for outpatient knee surgery. But to support his point, he uses one of his papers that has since been retracted for data fabrication.
A highly cited cancer researcher at MD Anderson has notched three major corrections, all associated with problems in figures. One note cites “human error” as the cause.
Chronic fatigue syndrome researcher Judy Mikovits was scheduled to head is heading to court today, where a California judge will would decide whether or not to dismiss her lawsuit against fourteen people and two Nevada corporations.
(Note: This story has been updated. See below.)
Among the defendants: the Whittemore Peterson Institute in Reno, Nevada where Mikovits used to work; the institute’s cofounders, Annette and Harvey Whittemore; a colleague with whom she shares a retracted Science paper; and several members of California and Nevada law enforcement.
The complaint does not check the box next to “Money Demanded in Complaint”, but also lists $750,000 in the associated field:
A heart researcher who fabricated patient records for her studies on the blood pressure medication ramipril has earned her fourth retraction, and more are apparently on the way.
For readers who are new to this case: Things first unraveled for Anna Ahimastos when a subanalysis of a JAMA clinical trial revealed “anomalies,” triggering an investigation. After Ahimastos admitted to fabricating patient data, that JAMA paper and two others — including a small trial in Annals of Internal Medicine — were pulled. A spokesperson for her former employer, Baker IDI Heart & Diabetes Institute, told us last week that they have requested more retractions:
Five papers and one letter are in the process of being retracted.
Following questions about the veracity of multiple papers by his former employer, high-profile social psychologist Jens Förster has agreed to retract two papers as part of a deal with the German Society for Psychology (DGPs).
Just two of those papers are acknowledged in the settlement of a case by the DGPs against Förster, who currently works at Ruhr University Bochum. Here’s a translation of a notice from the DGPs from One Hour Translation:
A heart researcher has notched her third retraction, a small 2006 trial in Annals of Internal Medicine which seemed to show that a blood pressure drug could help people with artery disease walk further with less pain.
Earlier this year, Anna Ahimastos, formerly a researcher at Baker IDI Heart and Diabetes Institute in Melbourne, lost a larger clinical trial in JAMA and a subanalysis in Circulation Research after it was discovered she’d fabricated patient records. As principle investigator Bronwyn Kingwell told us in September:
Specifically, records were fabricated for trial participants that did not exist.
Now, following an investigation by the institute, her co-authors are proactively retracting papers, with more to come. The Annals of Internal Medicine paper, “Ramipril Markedly Improves Walking Ability in Patients With Peripheral Arterial Disease,”is being pulled due to an “inability to adequately validate primary data sources.” According to the note, Ahimastos “maintains the integrity of the data and validity of reported results:”
Following five years of scrutiny, more than ten retractions, multiple settled lawsuits, and medical board reprimands, we may finally have some resolution on the case of Anil Potti, the once-rising cancer research star who resigned from Duke in 2010.
However, the report was kept secret — due, by some accounts, to alleged threats of a lawsuit. That is, until this year, when author Ranjit Kumar Chandra — who once dubbed himself the “father of nutritional immunology” — lost a $132 million libel case. That case, against the Canadian Broadcasting Company (CBC) for airing a three-part documentary series on allegations of fraud against Chandra, pushed the report by his former employer Memorial University of Newfoundland into the public domain.
At 26 years, the BMJ retraction is a runner up for the longest amount of time a journal has taken to retract a paper. (We know of another retraction that was 27 years in the making, and a scientist who requested the retraction of some passages of a 1955 article in 2007, after the article became fodder for creationists.)
We’ve learned about two more retractions we missed for Diederick Stapel, the Dutch social psychologyresearcher who has now racked up a total of 57 retractions by our count.
Both retractions were issued after a committee released a report which established fraud in dozens of papers co-authored by Stapel.
A retired obstetrics and gynecology professor under federal investigation for misconduct has notched his ninth retraction.
The latest retraction stems from an investigation by the University of Florida, where Nasser Chegini worked until 2012, which found fabricated data in three figures in a paper on the muscle cells that line the uterus.
The paper, “Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids,” was published in The Journal of Cellular and Molecular Medicine. It’s been cited 74 times, according to Thomson Scientific’s Web of Knowledge.